Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q2 2025 Earnings Call Transcript
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q2 2025 Earnings Call Transcript August 12, 2025Acumen Pharmaceuticals, Inc. misses on earnings expectations.
Acumen Pharmaceuticals Inc. (ABOS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 14,932,063 | $17,321,193 | 0.29% | |
| 2. | Millennium Management Israel Englander | 1,950,120 | $2,262,139 | +72% | 0% |
| 3. | Alyeska Investment Group Anand Parekh | 939,603 | $1,089,939 | 0% | |
| 4. | ADAR1 Capital Management Daniel Schneeberger | 916,183 | $1,062,772 | +527% | 0.16% |
| 5. | Laurion Capital Management Benjamin A. Smith | 867,046 | $1,005,773 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.75 | 5,161,290 | $39,999,997.50 | 13,043,179 | 2023-07-21 | Filing | |
| $16.00 | 35,000 | $560,000.00 | 172,324 | 2021-07-06 | Filing | |
| $16.00 | 312,500 | $5,000,000.00 | 3,352,693 | 2021-07-06 | Filing | |
| $16.00 | 750,000 | $12,000,000.00 | 3,951,156 | 2021-07-06 | Filing | |
| $16.00 | 6,250 | $100,000.00 | 6,250 | 2021-07-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.72 | 28,902 | $49,633.40 | 231,744 | 2025-01-23 | Filing | |
| $1.60 | 4,364 | $6,986.33 | 260,646 | 2025-01-21 | Filing | |
| $1.59 | 12,619 | $20,102.07 | 667,488 | 2025-01-21 | Filing | |
| $1.59 | 3,418 | $5,434.62 | 161,127 | 2025-01-21 | Filing | |
| $1.61 | 2,914 | $4,692.12 | 136,117 | 2025-01-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,417,075 | $3,963,807 | 0.78% | |
| 2. | 3,077,039 | $3,569,365 | 0% | |
| 3. | 2,029,736 | $2,354,494 | 0% | |
| 4. | 1,689,351 | $1,959,647 | 0% | |
| 5. | 1,628,510 | $1,889,072 | 0.18% |
News See All
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Acumen Pharmaceuticals Q1 2025 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2024 Earnings Call Transcript
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2024 Earnings Call Transcript March 27, 2025Acumen Pharmaceuticals, Inc. misses on earnings expectations.
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2024 Earnings Call Transcript
Alex Braun: Thanks, Tawanda. Good morning, and welcome to the Acumen conference call to discuss our business update and financial results for the quarter ended September 30, 2024.
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q2 2024 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to Acumen Pharmaceuticals Q2 2024 conference call and webcast. At this time, all participants are in a listen-only mode.
Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?
We recently compiled the list of the 7 Best Halal Stocks To Buy Now (Debt Free) according to the hedge funds using the latest sentiment data.
7 Best Halal Stocks To Buy Now (Debt Free)
Islamic equity investing, also known as Halal investing, has gained significant traction recently as Muslim investors seek to align their financial decisions with their religious beliefs.
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Acumen Pharmaceuticals First Quarter 2024 Conference Call and Webcast.
13 Best Penny Stocks to Buy According to Billionaire Ken Griffin
In this article, we will take a look at the 13 best penny stocks to buy according to billionaire Ken Griffin.
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen. Thank you for standing by. Welcome to Acumen Pharmaceuticals Full Year 2023 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
